Clinical and economic burden of antimicrobial resistance

Keyphrases

• Antimicrobial Resistance 100%
• Economic Burden 100%
• Treatment Burden 100%
• Length of Hospital Stay 33%
• Economic Outcomes 33%
• Clinical Outcomes 33%
• Clinical Impact 33%
• Economic Impact 33%
• Interpreting Studies 33%
• Antimicrobial-resistant Organisms 33%
• Adverse Outcomes 16%
• High Cost 16%
• Antimicrobial Therapy 16%
• Optimal Control 16%
• Healthcare Facilities 16%
• Antimicrobial 16%
• Health Care Costs 16%
• Patient Safety 16%
• Politicians 16%
• Increased Mortality 16%
• Enterococcus 16%
• Staphylococcus Aureus 16%
• Hospital Costs 16%
• Specific Interventions 16%
• Antibiotic Resistant 16%
• Funding Agencies 16%
• Existing Data 16%
• Multidrug-resistant Infection 16%
• New Antimicrobials 16%
• Gram-negative Bacilli 16%
• Limited Budget 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Antimicrobial Resistance 100%
• Infection 66%
• Antiinfective Agent 66%
• Adverse Outcome 16%
• Antibiotics 16%
• Infectious Agent 16%
• Enterococcus 16%
• Bacterial Infection 16%
• Staphylococcus Aureus 16%
• Gram Negative Bacterium 16%
• Antimicrobial Therapy 16%

Nursing and Health Professions

• Antimicrobial Resistance 100%
• Infection 66%
• Antiinfective Agent 66%
• Health Care Facility 16%
• Adverse Outcome 16%
• Hospitalization 16%
• Patient Safety 16%
• Hospital Cost 16%
• Antimicrobial Therapy 16%
• Bacterial Infection 16%